All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Cymabay Therapeutics Inc., of Newark, Calif., said it intends to offer and sell 10 million shares of its common stock, subject to market and other conditions, in an underwritten public offering.